Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.6M Buy
1,009,553
+99,931
+11% +$5.73M 0.01% 595
2025
Q4
$49.2M Buy
909,622
+870,079
+2,200% +$44.4M 0.01% 610
2025
Q3
$1.92M Sell
39,543
-12,304,338
-100% -$627M ﹤0.01% 1773
2025
Q2
$612M Buy
+12,343,881
New +$623M 0.12% 153

Other funds holding AMRZ

UBS AM's AMRZ Position: Q1 2026 in Review

UBS AM increased its Amrize Ltd (AMRZ) stake by 11% in Q1 2026, buying an estimated $5.73M and bringing the position to 1,009,553 shares worth $56.6M. The position accounts for 0.01% of the portfolio, ranked #595.

UBS AM first reported a position in AMRZ in Q2 2025 and has held it in 4 quarters since. The position peaked at $612M in Q2 2025. 447 funds tracked by Wall St. Rank hold AMRZ as of Q1 2026.

  • UBS AM held 1,009,553 shares of Amrize Ltd worth $56.6M as of Q1 2026.
  • UBS AM bought 99,931 Amrize Ltd shares in Q1 2026, an estimated $5.73M.
  • Amrize Ltd made up 0.01% of UBS AM's portfolio in Q1 2026, its #595 holding.
  • UBS AM first reported a position in Amrize Ltd in Q2 2025 and has held it in 4 quarters since.
  • UBS AM's Amrize Ltd position peaked at $612M in Q2 2025.
  • 447 funds tracked by Wall St. Rank held Amrize Ltd as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.